In vivo and in vitro study on the efficacy of terpinen-4-ol in dextran sulfate sodium-induced mice experimental colitis

Frontiers in Immunology

Volumn 8, Issue MAY, 2017, Pages

  Zhang, Zecai ^a   Shen, Peng ^a   Lu, Xiaojie ^a   Li, Yanxin ^a   Liu, Jiuxi ^a   Liu, Bo ^a   Fu, Yunhe ^a   Cao, Yongguo ^a   Zhang, Naisheng ^a  

^a JILIN UNIVERSITY   (China)

Author keywords

Colitis; Interleukin 1 ; Intestinal barrier; Intestinal microbiota; Lipopolysaccharide; NLRP3 inflammasome; Terpinen 4 ol

Indexed keywords

AMINO ACID TRANSPORTER; CRYOPYRIN; DEXTRAN SULFATE; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; MYELOPEROXIDASE; OCCLUDIN; PROTEIN ZO1; TERPINEN 4 OL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL VIABILITY; CONFOCAL LASER SCANNING MICROSCOPY; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOKINE RESPONSE; CYTOTOXICITY; DISEASE ACTIVITY SCORE; DRUG EFFICACY; DRUG MECHANISM; ENZYME ASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTAL COLITIS; FECES ANALYSIS; GENE EXPRESSION; HISTOPATHOLOGY; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; INTESTINE FLORA; MALE; MOUSE; MTT ASSAY; NONHUMAN; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TIGHT JUNCTION; WESTERN BLOTTING;

EID: 85020016786     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2017.00558     Document Type: Article

References (43)

1. Xavier RJ, Podolsky DK. Unravelling the pathogenesis of inflammatory bowel disease. Nature (2007) 448(7152):427-34. doi: 10.1038/nature06005
2. Cosnes J, Gower-Rousseau C, Seksik P, Cortot A. Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology (2011) 140(6):1785-94. doi:10.1053/j.gastro.2011.01.055
3. Terzic J, Grivennikov S, Karin E, Karin M. Inflammation and colon cancer. Gastroenterology (2010) 138(6):2101-14.e5. doi:10.1053/j.gastro.2010.01.058
4. Rowlinson A. Inflammatory bowel disease. 1: aetiology and pathogenesis. Br J Nurs (1999) 8(13):858-62. doi:10.12968/bjon.1999.8.13.6556
5. Yadav PN, Liu Z, RafiMM. A diarylheptanoid from lesser galangal (Alpinia officinarum) inhibits proinflammatory mediators via inhibition of mitogen-activated protein kinase, p44/42, and transcription factor nuclear factor-kappa B. J Pharmacol Exp Ther (2003) 305(3):925-31. doi:10.1124/jpet.103.049171
6. Zhang J, Fu S, Sun S, Li Z, Guo B. Inflammasome activation has an important role in the development of spontaneous colitis. Mucosal Immunol (2014) 7(5):1139-50. doi:10.1038/mi.2014.1
7. Mazmanian SK, Round JL, Kasper DL. A microbial symbiosis factor prevents intestinal inflammatory disease. Nature (2008) 453(7195):620-5. doi:10.1038/nature07008
8. Hill DA, Artis D. Intestinal bacteria and the regulation of immune cell homeostasis. Annu Rev Immunol (2010) 28:623-67. doi:10.1146/annurev-immunol-030409-101330
9. Sartor RB. Microbial influences in inflammatory bowel diseases. Gastroenterology (2008) 134(2):577-94. doi:10.1053/j.gastro.2007.11.059
10. Chung HY, Lee EK, Choi YJ, Kim JM, Kim DH, Zou Y, et al. Molecular inflammation as an underlying mechanism of the aging process and age-related diseases. J Dent Res (2011) 90(7):830-40. doi:10.1177/0022034510387794
11. Kim KA, Gu W, Lee IA, Joh EH, Kim DH. High fat diet-induced gut microbiota exacerbates inflammation and obesity in mice via the TLR4 signaling pathway. PLoS One (2012) 7(10):e47713. doi:10.1371/journal.pone.0047713
12. Park EJ, Thomson AB, Clandinin MT. Protection of intestinal occludin tight junction protein by dietary gangliosides in lipopolysaccharide-induced acute inflammation. J Pediatr Gastroenterol Nutr (2010) 50(3):321-8. doi:10.1097/MPG.0b013e3181ae2ba0
13. Trivedi PP, Jena GB. Melatonin reduces ulcerative colitis-associated local and systemic damage in mice: investigation on possible mechanisms. Dig Dis Sci (2013) 58(12):3460-74. doi:10.1007/s10620-013-2831-6
14. Okayasu I, Hatakeyama S, Yamada M, Ohkusa T, Inagaki Y, Nakaya R. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology (1990) 98(3):694-702. doi:10.1016/0016-5085(90)90290-H
15. Valatas V, Bamias G, Kolios G. Experimental colitis models: insights into the pathogenesis of inflammatory bowel disease and translational issues. Eur J Pharmacol (2015) 759:253-64. doi:10.1016/j.ejphar.2015.03.017
16. Bressler B, Marshall JK, Bernstein CN, Bitton A, Jones J, Leontiadis GI, et al. Clinical practice guidelines for the medical management of nonhospitalized ulcerative colitis: the Toronto consensus. Gastroenterology (2015) 148(5):1035-58.e3. doi:10.1053/j.gastro.2015.03.001
17. Brand C, Ferrante A, Prager RH, Riley TV, Carson CF, Finlay-Jones JJ, et al. The water-soluble components of the essential oil of Melaleuca alternifolia (tea tree oil) suppress the production of superoxide by human monocytes, but not neutrophils, activated in vitro. Inflamm Res (2001) 50(4):213-9. doi:10.1007/s000110050746
18. Hart PH, Brand C, Carson CF, Riley TV, Prager RH, Finlay-Jones JJ. Terpinen-4-ol, the main component of the essential oil of Melaleuca alternifolia (tea tree oil), suppresses inflammatory mediator production by activated human monocytes. Inflamm Res (2000) 49(11):619-26. doi:10.1007/s000110050639
19. Park MJ, Choi WS, Kang HY, Gwak KS, Lee GS, Jeung EB, et al. Inhibitory effect of the essential oil from Chamaecyparis obtusa on the growth of food-borne pathogens. J Microbiol (2010) 48(4):496-501. doi:10.1007/s12275-010-9327-2
20. Alex P, Zachos NC, Nguyen T, Gonzales L, Chen TE, Conklin LS, et al. Distinct cytokine patterns identified from multiplex profiles of murine DSS and TNBS-induced colitis. Inflamm Bowel Dis (2009) 15(3):341-52. doi:10.1002/ibd.20753
21. Dieleman LA, Palmen MJ, Akol H, Bloemena E, Pena AS, Meuwissen SG, et al. Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines. Clin Exp Immunol (1998) 114(3):385-91. doi:10.1046/j.1365-2249.1998.00728.x
22. Dieleman LA, Hoentjen F, Qian BF, Sprengers D, Tjwa E, Torres MF, et al. Reduced ratio of protective versus proinflammatory cytokine responses to commensal bacteria in HLA-B27 transgenic rats. Clin Exp Immunol (2004) 136(1):30-9. doi:10.1111/j.1365-2249.2004.02410.x
23. Ruyssers NE, De Winter BY, De Man JG, Loukas A, Pearson MS, Weinstock JV, et al. Therapeutic potential of helminth soluble proteins in TNBS-induced colitis in mice. Inflamm Bowel Dis (2009) 15(4):491-500. doi:10.1002/ibd.20787
24. Liu YZ, Cao YG, Ye JQ, Wang WG, Song KJ, Wang XL, et al. Immunomodulatory effects of proanthocyanidin A-1 derived in vitro from Rhododendron spiciferum. Fitoterapia (2010) 81(2):108-14. doi:10.1016/j.fitote.2009.08.005
25. Turnbaugh PJ, Hamady M, Yatsunenko T, Cantarel BL, Duncan A, Ley RE, et al. A core gut microbiome in obese and lean twins. Nature (2009) 457(7228):480-4. doi:10.1038/nature07540
26. Rand TG, Sun M, Gilyan A, Downey J, Miller JD. Dectin-1 and inflammation-associated gene transcription and expression in mouse lungs by a toxic (1, 3)-beta-D glucan. Arch Toxicol (2010) 84(3):205-20. doi:10.1007/s00204-009-0481-4
27. Cooper HS, Murthy SN, Shah RS, Sedergran DJ. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest (1993) 69(2):238-49
28. Baumgart DC, Sandborn WJ. Inflammatory bowel disease: clinical aspects and established and evolving therapies. Lancet (2007) 369(9573):1641-57. doi:10.1016/S0140-6736(07)60751-X
29. Lu A, Magupalli VG, Ruan J, Yin Q, Atianand MK, Vos MR, et al. Unified polymerization mechanism for the assembly of ASC-dependent inflammasomes. Cell (2014) 156(6):1193-206. doi:10.1016/j.cell.2014.02.008
30. Latz E, Xiao TS, Stutz A. Activation and regulation of the inflammasomes. Nat Rev Immunol (2013) 13(6):397-411. doi:10.1038/nri3452
31. Schroder K, Zhou R, Tschopp J. The NLRP3 inflammasome: a sensor for metabolic danger? Science (2010) 327(5963):296-300. doi:10.1126/science.1184003
32. Schroder K, Tschopp J. The inflammasomes. Cell (2010) 140(6):821-32. doi:10.1016/j.cell.2010.01.040
33. Loher F, Bauer C, Landauer N, Schmall K, Siegmund B, Lehr HA, et al. The interleukin-1 beta-converting enzyme inhibitor pralnacasan reduces dextran sulfate sodium-induced murine colitis and T helper 1 T-cell activation. J Pharmacol Exp Ther (2004) 308(2):583-90. doi:10.1124/jpet.103.057059
34. Allen IC, TeKippe EM, Woodford RM, Uronis JM, Holl EK, Rogers AB, et al. The NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer. J Exp Med (2010) 207(5):1045-56. doi:10.1084/jem.20100050
35. McGuckin MA, Eri R, Simms LA, Florin TH, Radford-Smith G. Intestinal barrier dysfunction in inflammatory bowel diseases. Inflamm Bowel Dis (2009) 15(1):100-13. doi:10.1002/ibd.20539
36. Bashashati M, Habibi HR, Keshavarzian A, Schmulson M, Sharkey KA. Intestinal microbiota: a regulator of intestinal inflammation and cardiac ischemia? Curr Drug Targets (2015) 16(3):199-208. doi:10.2174/1389450116666150120104012
37. Kucharzik T, Walsh SV, Chen J, Parkos CA, Nusrat A. Neutrophil transmigration in inflammatory bowel disease is associated with differential expression of epithelial intercellular junction proteins. Am J Pathol (2001) 159(6):2001-9. doi:10.1016/S0002-9440(10)63051-9
38. Suzuki T. Regulation of intestinal epithelial permeability by tight junctions. Cell Mol Life Sci (2013) 70(4):631-59. doi:10.1007/s00018-012-1070-x
39. Jeong JJ, Kim KA, Jang SE, Woo JY, Han MJ, Kim DH. Orally administrated Lactobacillus pentosus var. plantarum C29 ameliorates age-dependent colitis by inhibiting the nuclear factor-kappa B signaling pathway via the regulation of lipopolysaccharide production by gut microbiota. PLoS One (2015) 10(2):e0116533. doi:10.1371/journal.pone.0116533
40. Farrell RJ, LaMont JT. Microbial factors in inflammatory bowel disease. Gastroenterol Clin North Am (2002) 31(1):41-62. doi:10.1016/S0889-8553(01)00004-8
41. Chen LL, Wang XH, Cui Y, Lian GH, Zhang J, Ouyang CH, et al. Therapeutic effects of four strains of probiotics on experimental colitis in mice. World J Gastroenterol (2009) 15(3):321-7. doi:10.3748/wjg.15.321
42. Jeong JJ, Kim KA, Jang SE, Woo JY, Han MJ, Kim DH. Correction: orally administrated Lactobacillus pentosus var. plantarum C29 ameliorates age-dependent colitis by inhibiting the nuclear factor-kappa B signaling pathway via the regulation of lipopolysaccharide production by gut microbiota. PLoS One (2015) 10(11):e0142521. doi:10.1371/journal.pone.0142521
43. Matsuoka K, Kanai T. The gut microbiota and inflammatory bowel disease. Semin Immunopathol (2015) 37(1):47-55. doi:10.1007/s00281-014-0454-4